Table 3. Median survival times and prognostic points of 401 patients with advanced hepatocellular carcinoma.
| Variable | No. of patients | Median survival time (months) | P | β | Points |
|---|---|---|---|---|---|
| Age (≥50 vs. <50 years) | 165/236 | 18/10 | 0.013 | 0.242 | 1 |
| body mass index (≥18.5 vs. <18.5) | 358/43 | 13/8 | 0.031 | 0.467 | 2 |
| Alkaline phosphatase (≥80 vs. <80 U/l) | 221/180 | 11/19 | <0.001 | 0.439 | 2 |
| Tumor number (>1 vs. 1) | 169/232 | 11/15 | <0.001 | 0.341 | 1.5 |
| Tumor capsule (complete vs. incomplete/absent) | 105/296 | 20/11 | 0.001 | 0.426 | 2 |
| Prognostic points (≤3.5 vs. >3.5) | 177/224 | 23/9 | <0.001 |